Schedule 13D ownership disclosure

Juno Therapeutics, Inc.

Security class unavailable · CUSIP: 48205A109

Event date: 2015-08-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
9.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001571049-15-006186
Form type
SC 13D/A
Filer
Celgene Rivot Ltd
CIK
CIK 1646600
Filed
Aug 04, 2015
Reporting period
Aug 04, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub